NGL Fine-ChemNSE:NGLFINE +0.78%78 Gross Margin % is 52.49% as of Mar. 2026, which is 4% below its 10-year median of 54.90. GuruFocus rates NSE:NGLFINE with a GF Score™ of 78/100 and a GF Value™ of ₹2,811.32 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 936 Drug Manufacturers companies, NGL Fine-Chem ranks better than 55.56% on this metric.
NGL Fine-Chem Ltd gross margin has been in long-term decline. The average rate of decline per year is -2.2%.
The historical rank and industry rank for NGL Fine-Chem's Gross Margin % or its related term are showing as below:
NSE:NGLFINE'
s Gross Margin % Range Over the Past 10 Years
Min: 48.71 Med: 54.9 Max: 60.53
Current: 52.2
During the past 13 years, the highestGross Margin % of NGL Fine-Chem was 60.53%. The lowest was 48.71%. And the median was 54.90%.
NSE:NGLFINE's Gross Margin % is ranked better than 55.56% of 936
companies
in the Drug Manufacturers industry
Industry Median: 48.5
vs NSE:NGLFINE: 52.20
NGL Fine-Chem had a gross margin of 52.49% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for NGL Fine-Chem was -2.20% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
NGL Fine-Chem had a gross margin of 52.49% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
NGL Fine-Chem Gross Margin % Related Terms
NGL Fine-Chem Gross Margin % Historical Data
* Premium members only.
The historical data trend for NGL Fine-Chem's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:NGLFINE vs LLY, JNJ, ABBV: Gross Margin % Comparison
For the Drug Manufacturers - General subindustry, NGL Fine-Chem's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NGL Fine-Chem Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, NGL Fine-Chem's Gross Margin % distribution charts can be found below:
* The bar in red indicates where NGL Fine-Chem's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
NGL Fine-Chem (NSE:NGLFINE) has a Gross Margin % of 52.49% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on NGL Fine-Chem and its competitors. This is near median its historical median of 54.90. Over the past decade, NGL Fine-Chem's Gross Margin % has ranged from 48.71 to 60.53. According to the industry distribution chart, NGL Fine-Chem ranks #416 out of 936 companies in the Drug Manufacturers industry, placing it in the top 44.4%.
Is NGL Fine-Chem's Gross Margin % too high?
NGL Fine-Chem's current Gross Margin % of 52.49% is near median its 10-year median of 54.90. Over the past 10 years, this metric has ranged from a low of 48.71 to a high of 60.53. The Drug Manufacturers industry median Gross Margin % is 48.50. NGL Fine-Chem's value of 52.49% is 8.2% above this industry median. Based on the distribution chart, NGL Fine-Chem ranks #416 out of 936 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, NGL Fine-Chem has a GF Score™ of 78/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NGL Fine-Chem's Gross Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, NGL Fine-Chem ranks #416 out of 936 companies for Gross Margin %. This puts NGL Fine-Chem in the upper half of its industry. The industry median Gross Margin % is 48.50. NGL Fine-Chem's value of 52.49% is 8.2% above this benchmark. Historically, NGL Fine-Chem's own Gross Margin % has ranged from 48.71 to 60.53 over the past decade. While the company's 10-year median is 54.90 vs. the industry median of 48.50, NGL Fine-Chem has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.50, based on 936 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NGL Fine-Chem's current Gross Margin % of 52.49% is 8.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on NGL Fine-Chem and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NGL Fine-Chem's current Gross Margin % is 52.49%, which is near median its own 10-year median of 54.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NGL Fine-Chem stock overvalued right now?
Based on GuruFocus' analysis, NGL Fine-Chem (NSE:NGLFINE) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹2,811.32, compared to a current price of ₹3,107.50 — trading 10.5% above its estimated fair value. The current Gross Margin % is 52.49%, which is near median its 10-year median of 54.90 and 8.2% above the Drug Manufacturers industry median of 48.50. NGL Fine-Chem's overall GF Score™ is 78/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For NGL Fine-Chem (NSE:NGLFINE), the current Gross Margin % is 52.49% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NGL Fine-Chem (NSE:NGLFINE) Overvalued in 2026?
Based on GuruFocus' analysis, NGL Fine-Chem stock appears to be overvalued.
The current stock price of ₹3,107.50 is trading 10.5% above its estimated GF Value™ of ₹2,811.32.
GuruFocus considers NGL Fine-Chem to be Modestly Overvalued.
Key valuation signals for NSE:NGLFINE:
Gross Margin %: 52.49% (near median its 10-year median of 54.90)
GF Value™: ₹2,811.32 vs. price of ₹3,107.50 (10.5% above fair value)
Industry Position: 8.2% above the Drug Manufacturers median (#416 of 936)
No single metric tells the full story. See the NSE:NGLFINE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NGL Fine-Chem Ltd is an Indian company engaged in the pharmaceutical business. It is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health, catering to various companies to custom-manufacture pharmaceuticals. The company's product portfolio comprises animal health APIs such as homidium chloride, nitroxynil, clorsulon, decoquinate, fenbendazole, etc.; human health APIs such as nitazoxanide and atovaquone; drug intermediates and specialty chemicals; and finished dosage forms such as diminazene aceturate granules and homidium chloride tablets. Geographically, the group generates maximum revenue from the Asia-Pacific region, and the rest from India, Europe, the USA, and the rest of the world.
78GF Score
Get the complete analysis for NSE:NGLFINE
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:NGLFINE has been successfully added to your 
